Entrada Therapeutics Inc (TRDA)
17.74
+0.14
(+0.82%)
USD |
NASDAQ |
Nov 04, 16:00
17.76
+0.01
(+0.06%)
After-Hours: 20:00
Entrada Therapeutics Price to Book Value: 1.535 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.523 |
| October 31, 2024 | 1.483 |
| October 30, 2024 | 1.491 |
| October 29, 2024 | 1.495 |
| October 28, 2024 | 1.503 |
| October 25, 2024 | 1.470 |
| October 24, 2024 | 1.457 |
| October 23, 2024 | 1.468 |
| October 22, 2024 | 1.482 |
| October 21, 2024 | 1.499 |
| October 18, 2024 | 1.509 |
| October 17, 2024 | 1.526 |
| October 16, 2024 | 1.528 |
| October 15, 2024 | 1.517 |
| October 14, 2024 | 1.543 |
| October 11, 2024 | 1.452 |
| October 10, 2024 | 1.368 |
| October 09, 2024 | 1.399 |
| October 08, 2024 | 1.418 |
| October 07, 2024 | 1.431 |
| October 04, 2024 | 1.477 |
| October 03, 2024 | 1.422 |
| October 02, 2024 | 1.410 |
| October 01, 2024 | 1.384 |
| September 30, 2024 | 1.383 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.423 |
| September 26, 2024 | 1.364 |
| September 25, 2024 | 1.302 |
| September 24, 2024 | 1.332 |
| September 23, 2024 | 1.261 |
| September 20, 2024 | 1.270 |
| September 19, 2024 | 1.298 |
| September 18, 2024 | 1.181 |
| September 17, 2024 | 1.225 |
| September 16, 2024 | 1.259 |
| September 13, 2024 | 1.298 |
| September 12, 2024 | 1.286 |
| September 11, 2024 | 1.286 |
| September 10, 2024 | 1.274 |
| September 09, 2024 | 1.300 |
| September 06, 2024 | 1.281 |
| September 05, 2024 | 1.332 |
| September 04, 2024 | 1.332 |
| September 03, 2024 | 1.354 |
| August 30, 2024 | 1.532 |
| August 29, 2024 | 1.514 |
| August 28, 2024 | 1.412 |
| August 27, 2024 | 1.445 |
| August 26, 2024 | 1.463 |
| August 23, 2024 | 1.429 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6208
Minimum
May 09 2022
3.069
Maximum
Oct 31 2022
1.768
Average
1.795
Median
Jan 31 2023
Price to Book Value Benchmarks
| Fulcrum Therapeutics Inc | 0.7441 |
| Sarepta Therapeutics Inc | 10.90 |
| Catalyst Pharmaceuticals Inc | 4.240 |
| Vertex Pharmaceuticals Inc | 8.267 |
| Regenxbio Inc | 1.245 |
Price to Book Value Related Metrics
| PE Ratio | 5.995 |
| PS Ratio | 2.566 |
| Price | 17.74 |
| Earnings Yield | 16.68% |
| Market Cap | 660.11M |
| Operating PE Ratio | 6.572 |
| Normalized PE Ratio | 5.995 |